Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism (Q45310537)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q44026330)
(P304) 591-601
(P433) 3
(P478) 18
(P577) Friday, April 1, 2005
(P921) (Q422936)
(Q11085)
(P1433) (Q15716606)
(P1476) "Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism" (language: en)
(P2093) Isabel Caraballo
Fernando Rodriguez de Fonseca
Fadwa El Banoua
Belen Ferrer
Juan A Flores
Beatriz Galan-Rodriguez
other details
description scientific article

External Links